UBC’s Post

SitePlus – developed in partnership with THREAD – has been enhanced to offer advanced central site services and technology features for both interventional and post-approval research studies. This joint offering provides a proven, next-generation research model that can be initiated from initial study design and launch or added alongside any ongoing Phase II – IV study. Learn more about how SitePlus can help you by bring the promise of hybrid study designs to life through expanding access to addressable patient populations, accelerating enrollment, and improving patient retention. Discover how SitePlus is keeping patients engaged and transforming how studies are designed, and data is captured https://hubs.li/Q02BPm-r0 #PatientsFirst #SitePlus #Pharma #ClinicalTrials #CRO

UBC's REMS leaders will be at the REMS Innovation Summit later this month - join us there as we and other industry leaders discuss the future of these programs! To learn more about our industry-leading solutions and our featured presentation, visit https://hubs.li/Q02FsxM60 #PatientsFirst #REMS #REMSSummit #PatientSafety

Are you utilizing tokenization to gain wider insights about your clinical trial population outside of the confines of the trial? Learn more about recent changes and use cases for RWD enrichment studies at https://hubs.li/Q02C-DTL0 #PatientsFirst #RWD #RWE #ClinicalTrials

Don’t wait until increasing pharmacovigilance (PV) case volume overwhelms your resources. Implement UBC’s PV Case Automation Platform to easily control high-volume case processing with the automation of mailbox management, case intake, translation management, work assignment and more. Download our case study for insight into this real-time, scalable case automation solution to streamline your PV operations and cut costs. https://hubs.li/Q02DcxHt0 #PatientsFirst #Pharmacovigilance #SafetyandRiskManagement #PatientSafety #PVAutomation

We are excited to announce the expansion of our joint SitePlus offering in collaboration with THREAD. The expanded solution has been purposefully assembled to bring hybrid designs to life in the Phase II/III interventional clinical trial setting. SitePlus combines a nationwide investigator network, full-service study coordinator capabilities, and robust clinical trial home nursing reach, all connected and operating on a centralized technology platform. Click here to learn more https://hubs.li/Q02D9Pw70 #PatientsFirst #SitePlus #Pharma #ClinicalTrials #RWE

If you missed UBC's Innovation Theater at DIA 2024 last week you can catch up on our presentation topic. Read about RWD enrichment studies from UBC's Jeff Lowry and Irene Cosmatos at https://hubs.li/Q02C-DTJ0 #PatientsFirst #DIA2024 #RWD #RWE

Patient access programs thrive when they are supported by actionable data and the right technology. Learn how UBC’s success for rare disease patients is evolving and impacting patients: https://hubs.li/Q02zmC5z0 #PatientsFirst #PatientAccess #PatientSupport #RareDisease

Meet Myrto Ioannidi, MSc. Mrs. Ioannidi has over 10 years PV experience at UBC and currently leads a global team responsible for case processing, expedited reporting, literature review, safety database configuration and aggregate data outputs. As Director of Global Case Processing, Mrs. Ioannidi also acts as PV process lead for global and local literature and case automation. Read her full bio here. https://hubs.li/Q02CrGBn0 #PatientsFirst #Pharmacovigilance #SafetyandRiskManagement #PatientSafety

Managing pharmacovigilance (PV) data optimization and adhering to evolving regulatory requirements doesn’t have to be a challenge. Experience seamless, real-time data visualization and compliance management with UBC’s PV Tableau Data Analytics Platform. Our solution is customized to your needs with an intuitive, dynamic data dashboard system and easy on-demand accessibility to generate powerful insights. Get the details: https://hubs.li/Q02CvbQP0 #PatientsFirst #Pharmacovigilance #SafetyandRiskManagement #PatientSafety #PVAnalytics